- Title: Subtitle
- Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332
- Creators
- Sheri L. Spunt - Lucile Packard Children's HospitalLynn Million - Stanford UniversityJames Robert Anderson - University of Nebraska Medical CenterCheryl M. Coffin - Vanderbilt UniversityBeth McCarville - St. Jude Children's Research HospitalR. Lor Randall - Huntsman Cancer InstituteDavid Parham - Children's Hospital of Los AngelesSimon C Kao - University of IowaAndrea Anita Hayes-Jordan - The University of Texas MD Anderson Cancer CenterSuzanne L. Wolden - Memorial Sloan Kettering Cancer CenterStephanie Alicia Terezakis - Johns Hopkins MedicineJennifer Black - Vanderbilt UniversityFran Laurie - Quality Assurance Review CenterEllen Kawashima - Children's Oncology GroupRose Anne Speights - St. Jude Children's Research HospitalStephen Skapek - The University of Texas Southwestern Medical CenterWilliam H. Meyer - University of Oklahoma Health Sciences CenterDouglas S. Hawkins - Seattle Children's HospitalAlberto S. Pappo - St. Jude Children's Research Hospital
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.10008-10008
- DOI
- 10.1200/jco.2014.32.15_suppl.10008
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2014
- Academic Unit
- Radiology; Stead Family Department of Pediatrics
- Record Identifier
- 9984320098002771
Abstract
Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332
Journal of clinical oncology, Vol.32(15_suppl), pp.10008-10008
05/20/2014
DOI: 10.1200/jco.2014.32.15_suppl.10008
Details
Metrics
1 Record Views